Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336869
Status:
COMPLETED
Last Update Posted:
2013-11-18
First Post:
2006-06-12
Brief Title:
Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership
Sponsor:
Emory University
Organization:
Emory University
Study Overview
Official Title:
Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Meta-Health
Brief Summary:
The theme of this Morehouse-Emory Partnership Program focuses on elucidating the etiologic basis of ethnic differences in obesity-related CVD and discovering new intervention strategies to ameliorate CV health in all communities The proposed Program uses a multi-disciplinary strategy to systematically characterize ethnic differences in obesity-related CVD by drawing upon the fields of physiology psychology biochemistry vascular biology public health nursing and clinical medicine
Detailed Description:
Emerging evidence indicates that there are ethnicity-specific differences in the profile of biochemical metabolic and physiological perturbations associated with obesity The implications of these ethnic differences remain to be further defined Several epidemiologic studies have shown that vascular disease and its cardiovascular complications carry significantly higher morbidity and mortality in African Americans compared with Caucasians1-3 These observations may be partly explained by a higher prevalence of cardiovascular disease risk factors such as essential hypertension diabetes mellitus and tobacco use among African Americans4-6 However the pathophysiological processes underlying this racial predisposition have not been fully elucidated7 It is likely that the etiologic basis of ethnic disparities in cardiovascular disease is multi-factorial and involves dynamic gene-environment interactions in which variances in behavior and the social context are critical determinants
The proposed Program recognizes the importance of incorporating both biological factors and social determinants in the analysis of cardiovascular disparities
The proposed Program recognizes the importance of incorporating both biological factors and social determinants in the analysis of cardiovascular disparities
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1024-2004 | OTHER | Other | None |